Sank Leonard

Average Profitability
53.34%
Insider Buys Quantity
12
Insider Buys Sum
$998,825.20
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Sank Leonard

The largest purchase of all time was on 2011-10-04 and amounted to 937500 shares of Oramed Pharmaceuticals Inc. for $300,000.

Biography of Sank Leonard

No biography is available at this moment.

2019-09-09PurchaseOramed Pharmaceuticals Inc.
ORMP
director
50,000
0.2901%
$2.92$146,000+20.49%
2019-07-18PurchaseOramed Pharmaceuticals Inc.
ORMP
director
8,994
0.0501%
$3.85$34,672-15.66%
2019-07-17PurchaseOramed Pharmaceuticals Inc.
ORMP
director
60,040
0.3268%
$3.63$218,118-12.57%
2019-07-16PurchaseOramed Pharmaceuticals Inc.
ORMP
director
40,000
0.2278%
$3.52$140,878-5.65%
2019-07-11PurchaseOramed Pharmaceuticals Inc.
ORMP
director
2,640
0.0147%
$3.22$8,501+1.21%
2011-10-04PurchaseOramed Pharmaceuticals Inc.
ORMP
director
937,500
1.1494%
$0.32$300,000-13.51%
2008-01-16PurchaseOramed Pharmaceuticals Inc.
ORMP
director
5,000
0.0109%
$0.25$1,250+132%
2008-01-15PurchaseOramed Pharmaceuticals Inc.
ORMP
director
15,650
0.034%
$0.25$3,913+132%
2008-01-07PurchaseOramed Pharmaceuticals Inc.
ORMP
director
45,680
0.1027%
$0.30$13,704+98.28%
2008-01-03PurchaseOramed Pharmaceuticals Inc.
ORMP
director
48,000
0.1043%
$0.30$14,400+93.33%
2008-01-02PurchaseOramed Pharmaceuticals Inc.
ORMP
director
242,320
0.5038%
$0.30$71,896+87.1%
2007-12-31PurchaseOramed Pharmaceuticals Inc.
ORMP
director
190,000
0.38%
$0.24$45,494+123.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.